Market Cap

Tanvex BioPharma, Inc. Market Capitalization:

TW$10.88 Billion

TWD as of July 1, 2024

US$334.0 Million

business Tanvex BioPharma, Inc. Company Profile

Tanvex BioPharma, Inc. Main Stock Listing

TWSE: 6541

Market Capitalization History of Tanvex BioPharma, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Tanvex BioPharma, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$8.46 B -36.61%
Jan. 1, 2023 TW$13.35 B -28.85%
Jan. 1, 2022 TW$18.76 B 51.57%
Jan. 1, 2021 TW$12.38 B -15.93%
Jan. 1, 2020 TW$14.72 B -38.74%
Jan. 1, 2019 TW$24.03 B -20.43%
Jan. 1, 2018 TW$30.20 B -34.39%
Jan. 1, 2017 TW$46.03 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Tanvex BioPharma, Inc. Categories

languages Healthcare languages Biotechnology

Stocks & Indices

Tanvex BioPharma, Inc. has the following listings and related stock indices.


Stock: TWSE: 6541

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.